Introduction
Extraosseous osteogenic sarcoma of the somatic soft tissue is an extremely rare type of tumor, constituting only 1.2% of all soft tissue sarcomas. 1 The first case was reported by Wilson in 1941 . 2 Since then, less than 200 cases have been reported in the English literature. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] The tumors occur in middle-aged and elderly patients. A previous report showed that the response of extraosseous osteogenic sarcoma to multimodality therapy is not as good as that of intraosseous osteogenic sarcoma. 4 Out of the more than 400 cases of soft tissue sarcomas on file in our hospital, only 2 were extraosseous osteogenic sarcomas. The present study reviews these 2 cases from all of the 102 osteogenic sarcomas recorded at our institution during the 10-year period from 1990 to 1999.
Case Reports

Case 1
A 68-year-old woman had noted a small mass over her left thigh since the early 1970s, after a fall from a stairway. In the past 8 months, the mass progressively On physical examination, a tender movable soft tissue mass, about 8 cm in diameter, over the medial aspect of her left thigh was found. Radiography revealed a soft tissue mass with calcification over the left thigh ( Figure 1 ). As the mass had grown very slowly over the years, the initial impression was that it was a benign lesion. Computer tomography of the lungs and whole body bone scintigraphy showed no lung or bone involvement. The tumor, measuring 9 × 7 × 6 cm, was excised with a margin. Microscopically, a network of eosinophilic, irregular and glassy osteoid structures interposed with pleomorphic-nuclei spindle cells were seen ( Figure 2 ). The diagnosis of extraosseous osteogenic sarcoma was made. Fortunately, the cut margins and skin were free of tumor cells.
Extraosseous Osteogenic Sarcoma
As the margin of the tumor excision was not wide enough, postoperative radiotherapy with 60 Gy in 30 fractions was given. However, the patient refused any kind of chemotherapy. After 90 months of follow-up, she was alive without evidence of local recurrence or distant metastasis.
Case 2
A 69-year-old woman had undergone modified radical mastectomy for breast adenocarcinoma in 1974. After the operation, she was continuously free of the disease. However, she found a small nodule over her left thigh, just below the inguinal area, in March 1995, 3 months prior to presentation. The soft tissue mass grew rapidly and became painful. A plain radiograph and magnetic resonance imaging (MRI) of the left proximal femur showed a calcified soft tissue mass over the upper medial thigh without a skeletal lesion ( Figure 3) . As the mass grew rapidly and MRI showed central necrosis, malignancy was highly suspected. Wide excision was performed. The neurovascular bundle lateral to the mass was well protected and preserved. Histopathologic examination revealed extraosseous osteogenic sarcoma with muscle involvement (Figure 4) . The cut margins were free of tumor cells. Adjuvant chemotherapy with cisplatin and doxorubicin was administered postoperatively. No local recurrence or distant metastasis was noted from a postoperative 105-month follow-up.
Discussion
Extraosseous osteogenic sarcoma arising from soft tissue constitutes 1.2% of all soft tissue sarcomas. 1 At the Rosewell Park Memorial Institute, 4.6% of all osteogenic sarcomas were of soft tissue origin. A similar incidence has been reported by Allan and Soule, 1 and Wurlitzer et al. 3 At the Memorial Sloan-Kettering Cancer Center, a review of 48 cases of extraosseous osteogenic sarcoma during 1950-1983 showed the median age at diagnosis to be 51 years (range, 6-80 years). 4 The most common primary sites were the thighs and buttocks (26 cases, 54.2%). Spotty areas of calcification were seen in preoperative radiographs of the tumor in about half of the cases. Forty-one (91.1%) of the 45 patients who had been followed for more than 1 year developed local recurrence and/or distant metastasis.
A B
While osteogenic sarcoma of bone occurs most frequently in children and adolescents, patients with extraosseous osteogenic sarcomas are usually older than 40 years. A recent review of the literature placed the mean age of patients with extraosseous osteogenic sarcoma at 53 years. 5 Our 2 patients were older than 53 years of age (68 and 69 years). The common mode of presentation is swelling of insidious onset, with associated pain in approximately 1-third of patients. Frequently, the tumor grows to a large size before the patient seeks medical advice. The mean duration of symptoms before diagnosis was 3 months. 4 The duration of symptoms before diagnosis in our 2 patients were 8 and 3 months. Previous radiation therapy is a well-known predisposing factor for the development of both soft tissue and bone sarcoma. 6 The role of trauma in the incidence of extraosseous osteogenic sarcoma is controversial. Several authors have suggested that trauma can be an important etiologic factor in the development of these neoplasms. 7 One of our 2 patients had a history of trauma.
Radiographic examination of the soft tissue is essential to rule out any continuity of the tumor with bone. If adjacent bone shows radiologic changes of involvement by the tumor, it is most likely to be sarcoma originating from the bone rather than from the soft tissue. A soft tissue mass with spotty calcification without adjacent bone involvement is one of the classic radiographic appearances of this tumor, which were seen in our 2 cases.
C B A
The single most important criterion for diagnosis of this tumor is the presence of malignant osteoid. 8 Indeed, a variable amount of fibroblastic and chondroblastic components may also be present. In limited biopsy material, in the absence of malignant osteoid and malignant chondrocytes, extraosseous osteogenic sarcoma may resemble malignant giant cell tumor or malignant fibrous histiocytoma of soft tissue. Therefore, specific histologic identification should be done only after generous sampling of the neoplasm. In addition, this tumor should be differentiated from myositis ossificans. The presence of a wide spectrum of malignant neoplastic elements and conspicuous absence of inflammatory cells and areas of hemorrhagic necrosis help to rule out myositis ossificans.
Wide local excision, with at least a 5-cm margin of normal tissue, should be the treatment of choice. If this is not feasible due to the anatomic location of the tumor, amputation should be recommended. 9 Due to the high tendency of extraosseous osteogenic sarcoma to recur after resection, simple excision or enucleation of the tumor should not be considered. Since recurrence occurs mostly within 2 years after treatment, adjuvant chemotherapy and radiotherapy might be of benefit. However, a review of 48 cases of extraosseous osteogenic sarcoma and 39 trials of chemotherapy agents or combinations, including 16 combinations containing doxorubicin, showed that no patients had a major response. 4 The average 5-year survival rates in 5 previous studies range from 15% to 25%. 1, 3, 5, 6, 10 Around 80% of patients died within 2-3 years. These survival rates are comparable with those of "classic" type osteogenic sarcoma and poorly differentiated soft tissue sarcoma. Fortunately, both of our patients (1 received wide excision and adjuvant chemotherapy, the other received marginal excision and postoperative radiotherapy) continue to be disease-free. The reasons for these encouraging results are unknown, but we should not underestimate the severity of the disease. Careful preoperative evaluation and multimodal treatment are essential in the management of patients with extraosseous osteogenic sarcoma.
